000 | 01201 a2200337 4500 | ||
---|---|---|---|
005 | 20250515064217.0 | ||
264 | 0 | _c20080118 | |
008 | 200801s 0 0 eng d | ||
022 | _a1863-4362 | ||
024 | 7 |
_a10.1007/s11845-007-0026-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLangabeer, S E | |
245 | 0 | 0 |
_aIncidence and significance of the JAK2 V617F mutation in patients with chronic myeloproliferative disorders. _h[electronic resource] |
260 |
_bIrish journal of medical science _c |
||
300 |
_a105-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aJanus Kinase 2 _xgenetics |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aMyeloproliferative Disorders _xgenetics |
650 | 0 | 4 |
_aPolycythemia Vera _xgenetics |
650 | 0 | 4 | _aPolymerase Chain Reaction |
650 | 0 | 4 |
_aPrimary Myelofibrosis _xgenetics |
650 | 0 | 4 |
_aThrombocythemia, Essential _xgenetics |
700 | 1 | _aNi Ainle, F | |
700 | 1 | _aConneally, E | |
700 | 1 | _aLawler, M | |
773 | 0 |
_tIrish journal of medical science _gvol. 176 _gno. 2 _gp. 105-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11845-007-0026-x _zAvailable from publisher's website |
999 |
_c16990843 _d16990843 |